By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.

The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report ...

Dr. Jani highlighted the EMPIRE-1 trial, which evaluated the role of 18F-fluciclovine PET in guiding post-prostatectomy radiotherapy. The study demonstrated an improvement in 3-year freedom from ...

As part of our commitment, we've once again partnered with Statista, Inc. to evaluate the implementation of Patient Reported ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

The co-primary endpoints were safety and efficacy: efficacy defined as ≥25% reduction in rectal rV70 in >75% of balloon ...

According to a meta-analysis, patients’ baseline quality of life, functional scores, and symptom burden all predict cancer survival.

Panelists discuss how patient-reported outcomes including symptom burden, treatment-related adverse effects, preserved functionality, and impact on quality of life should be prioritized alongside ...

Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer Patients with locally advanced ...

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...

Certain patient-reported outcomes (PROs) can predict overall survival (OS) in patients with cancer, according to research published in JAMA Oncology. Researchers found that higher baseline scores in ...